Literature DB >> 23239117

Regulation of bone resorption and sealing zone formation in osteoclasts occurs through protein kinase B-mediated microtubule stabilization.

Takumi Matsumoto1, Yuichi Nagase, Jun Hirose, Naoto Tokuyama, Tetsuro Yasui, Yuho Kadono, Kohjiro Ueki, Takashi Kadowaki, Kozo Nakamura, Sakae Tanaka.   

Abstract

We investigated the role of protein kinase B (Akt), a downstream effector of phosphatidylinositol 3-kinase, in bone-resorbing activity of mature osteoclasts. Treatment with a specific Akt inhibitor disrupted sealing zone formation and decreased the bone-resorbing activity of osteoclasts. The normal microtubule structures were lost and the Akt inhibitor reduced the amount of acetylated tubulin, which reflects stabilized microtubules, whereas forced Akt activation by adenovirus vectors resulted in the opposite effect. Forced Akt activation increased the binding of the microtubule-associated protein adenomatous polyposis coli (APC), the APC-binding protein end-binding protein 1 (EB1) and dynactin, a dynein activator complex, with microtubules. Depletion of Akt1 and Akt2 resulted in a disconnection of APC/EB1 and a decrease in bone-resorbing activity along with reduced sealing zone formation, both of which were recovered upon the addition of LiCl, a glycogen synthase kinase-3β (GSK-3β) inhibitor. The Akt1 and Akt2 double-knockout mice exhibited osteosclerosis due to reduced bone resorption. These findings indicate that Akt controls the bone-resorbing activity of osteoclasts by stabilizing microtubules via a regulation of the binding of microtubule associated proteins.
Copyright © 2013 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23239117     DOI: 10.1002/jbmr.1844

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation.

Authors:  Luz M Castillo; Carlos A Guerrero; Orlando Acosta
Journal:  J Mol Histol       Date:  2017-03-25       Impact factor: 2.611

2.  BRD7 regulates the insulin-signaling pathway by increasing phosphorylation of GSK3β.

Authors:  Lena Golick; Youngah Han; Yoo Kim; Sang Won Park
Journal:  Cell Mol Life Sci       Date:  2017-11-10       Impact factor: 9.261

Review 3.  Bone regeneration in osteoporosis: opportunities and challenges.

Authors:  Dhrumi Patel; Sarika Wairkar
Journal:  Drug Deliv Transl Res       Date:  2022-08-22       Impact factor: 5.671

4.  Microtubule dynamic instability controls podosome patterning in osteoclasts through EB1, cortactin, and Src.

Authors:  Martin Biosse Duplan; Detina Zalli; Sebastien Stephens; Serhan Zenger; Lynn Neff; J Margit Oelkers; Frank P L Lai; William Horne; Klemens Rottner; Roland Baron
Journal:  Mol Cell Biol       Date:  2013-10-21       Impact factor: 4.272

5.  Lumican Inhibits Osteoclastogenesis and Bone Resorption by Suppressing Akt Activity.

Authors:  Jin-Young Lee; Da-Ae Kim; Eun-Young Kim; Eun-Ju Chang; So-Jeong Park; Beom-Jun Kim
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

6.  A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.

Authors:  Bingru Lu; Yulian Jiao; Yinchang Wang; Jing Dong; Muyun Wei; Bin Cui; Yafang Sun; Laicheng Wang; Bingchang Zhang; Zijiang Chen; Yueran Zhao
Journal:  Exp Mol Med       Date:  2017-05-19       Impact factor: 8.718

7.  A 15-amino acid C-terminal peptide of beta-defensin-3 inhibits bone resorption by inhibiting the osteoclast differentiation and disrupting podosome belt formation.

Authors:  Ok-Jin Park; Jiseon Kim; Ki Bum Ahn; Jue Yeon Lee; Yoon-Jeong Park; Kee-Yeon Kum; Cheol-Heui Yun; Seung Hyun Han
Journal:  J Mol Med (Berl)       Date:  2017-09-09       Impact factor: 4.599

Review 8.  The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis.

Authors:  Wacili Da; Lin Tao; Yue Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 5.555

9.  Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation.

Authors:  Xiaoqin Fan; Haiting Xiong; Jinmei Wei; Xuejuan Gao; Yuan Feng; Xiaohui Liu; Gong Zhang; Qing-Yu He; Jiake Xu; Langxia Liu
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

10.  Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions.

Authors:  Kelly Aukes; Cynthia Forsman; Nicholas J Brady; Kristina Astleford; Nicholas Blixt; Deepali Sachdev; Eric D Jensen; Kim C Mansky; Kathryn L Schwertfeger
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.